BioVendor, AIT Austrian Institute of Technology, and SCIENION are collaborating to jointly develop an in-vitro diagnostic test kit for colon cancer. The innovative test based on tumor autoantibody biomarkers shall identify cancer at an early stage.
Colon cancer is one of the most common cancers being the second most common cause of cancer in women and the third most common in men. Early detection of this serious disease increases both the therapeutic success and the chance of survival. The current diagnostic practice involves either uncomfortable invasive procedures or uses stool tests, the latter resulting in a high percentage of false-positive results.
